 |
 |
Company Overview
Union Springs Pharmaceuticals (USP) is a specialty OTC company that licenses, develops and commercializes innovative OTC products for the consumer and healthcare markets. We specialize in finding unique solutions for unmet consumer and healthcare professional needs. We provide focused, disciplined management to optimize products and technologies, and we apply industry-recognized scientific methods, clinical trials and testing methodologies to provide safe, effective products to our customers.
USP was formed by the Drug Enhancement Company of America (DECA) to commercialize products specifically targeted for the OTC market. DECA and members of its management team have developed both prescription and over-the-counter healthcare products and services and companies including Richwood Pharmaceuticals (now Shire), Xanodyne Pharmaceuticals, Integrity Pharmaceuticals, PediaMed and Hill Top Research. For more information about DECA, please visit www.DECAUSA.com.
Our Mission
Our mission is to provide innovative healthcare products that offer scientifically proven therapeutic advancements and which satisfy unmet needs of the worldwide consumer and healthcare professional markets.
Union Springs Pharmaceuticals, LLC is a wholly owned subsidiary of the Drug Enhancement Company of America, LLC (DECA), a pharmaceutical technology development company.
|
 |
|
